ICN Lowers Ownership in Syncor Stock
ICN Pharmaceuticals of Costa Mesa said it has lowered its stock ownership in Syncor International, a Chatsworth-based radio pharmaceuticals distributor, from slightly more than 5% to 4.8% of its common shares.
In a filing with the U.S. Securities and Exchange Commission, ICN said it holds 533,000 Syncor shares.
The company characterized its holdings in the company as “purely an investment†and said the recent sales were designed to balance ICN’s stock portfolio.
ICN is a pharmaceutical manufacturer and distributor.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
